Phased variants improve DLBCL minimal residual disease detection at the end of therapy.
暂无分享，去创建一个
Ash A. Alizadeh | W. Wilson | C. Liu | J. Chabon | D. Kurtz | M. Jin | Lyron Co Ting Keh | M. Diehn | D. Rossi | G. Gaidano | A. Schultz | J. Westin | F. Scherer | R. Casasnovas | S. Alig | M. Roschewski | U. Duehrsen | A. Craig | A. Huettmann | Joanne Soo